|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0022686,
umls-concept:C0023981,
umls-concept:C0024204,
umls-concept:C0040284,
umls-concept:C0205225,
umls-concept:C0282460,
umls-concept:C0684249,
umls-concept:C0879593,
umls-concept:C1516213,
umls-concept:C1522673,
umls-concept:C1879547
|
|
pubmed:issue |
2B
|
|
pubmed:dateCreated |
2008-5-28
|
|
pubmed:abstractText |
The efficacy and toxicity of adjuvant chemo-immunotherapy using dendritic cells and activated killer cells are not clear in post-surgical primary lung cancer patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1229-38
|
|
pubmed:meshHeading |
pubmed-meshheading:18505060-Adult,
pubmed-meshheading:18505060-Aged,
pubmed-meshheading:18505060-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18505060-Carboplatin,
pubmed-meshheading:18505060-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18505060-Chemotherapy, Adjuvant,
pubmed-meshheading:18505060-Dendritic Cells,
pubmed-meshheading:18505060-Female,
pubmed-meshheading:18505060-Humans,
pubmed-meshheading:18505060-Immunotherapy, Adoptive,
pubmed-meshheading:18505060-Lung Neoplasms,
pubmed-meshheading:18505060-Lymph Nodes,
pubmed-meshheading:18505060-Male,
pubmed-meshheading:18505060-Middle Aged,
pubmed-meshheading:18505060-Monocytes, Activated Killer,
pubmed-meshheading:18505060-Neoplasm Staging,
pubmed-meshheading:18505060-Paclitaxel,
pubmed-meshheading:18505060-Prognosis,
pubmed-meshheading:18505060-Prospective Studies,
pubmed-meshheading:18505060-Taxoids
|
|
pubmed:articleTitle |
Prospective phase II study of post-surgical adjuvant chemo-immunotherapy using autologous dendritic cells and activated killer cells from tissue culture of tumor-draining lymph nodes in primary lung cancer patients.
|
|
pubmed:affiliation |
Division of Thoracic Diseases, Chiba Cancer Center, Chuo-ku, Chiba City, Chiba, Japan. dclak@chiba-cc.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
